October 17, 2007 / 2:33 PM / 10 years ago

UPDATE 1-Nanosphere sees IPO of 7 mln shares at $14-$16 each

Oct 17 (Reuters) - Nanosphere Inc on Wednesday registered its initial public offering of 7 million shares at an estimated price of $14 to $16 per share.

The developer of diagnostic tests said in an amended filing with the U.S Securities and Exchange Commission that it expects proceeds of $95 million, assuming an IPO price of $15.

Nanosphere said it plans to use some of the proceeds to finance ongoing research to develop additional genomic and protein tests.

Credit Suisse, Piper Jaffray, Leerink Swann and Allen & Co LLC are underwriting the IPO and have an option to buy a maximum of about 1.1 million additional shares to cover over-allotments.

Nanosphere’s initial market capitalization will be in the region of $321.8 million, assuming an IPO price of $15 a share, the mid-point of its range.

The Northbrook, Illinois-based company, which reported a net loss of $15.1 million in the first half of 2007, said it applied for a Nasdaq listing under the symbol “NSPH.” (Reporting by Sayantani Ghosh in Bangalore)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below